DEANETT EVANS: Open Payments
NPI 1104571595 · WATERBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,794 in 239 payments from 27 companies in 2025. Trend: 2023 $2,981 · 2024 $3,686 · 2025 $4,794
Food & beverage: $4,571Education: $223
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $801 |
| GlaxoSmithKline, LLC. | 30 | $562 |
| Takeda Pharmaceuticals U.S.A., Inc. | 42 | $473 |
| GENZYME CORPORATION | 15 | $372 |
| Viatris Specialty LLC | 16 | $361 |
| Verona Pharma, Inc. | 14 | $305 |
| Regeneron Healthcare Solutions, Inc. | 10 | $281 |
| Amgen Inc. | 16 | $280 |
| Genentech USA, Inc. | 17 | $279 |
| Grifols USA, LLC | 12 | $203 |
Products named: DUPIXENT, TEZSPIRE, GLASSIA, NUCALA, YUPELRI, Ohtuvayre, Xolair, AIRSUPRA.
Industry payments across CT — which companies pay providers there.
